Pharmacists in Canton, New York


13 Pharmacists found in Canton
female pharmacist

Mrs. Brandi L Romano, RPH


Pharmacist
92 Co Rd 32, Canton, NY 13617
315-379-1431    

male pharmacist

Mr. Brook Wade Madlin, RPH


Pharmacist
19 Miner St, Canton, NY 13617
315-261-4182    

female pharmacist

Cynthia Young, R.PH.


Pharmacist
40 State Highway 310, Canton, NY 13617
315-386-4563    



female pharmacist

Haley Ann Brandes, PHARM D


Pharmacist
90 E Main St, Canton, NY 13617
315-386-8611     315-386-2858

male pharmacist

Dr. Jonathan M Kubinski, PHARM. D.


Pharmacist
111 E Main St, Canton, NY 13617
315-379-9620    

female pharmacist

Dr. Kiera E Warner, RPH


Pharmacist
40 State Highway 310, Canton, NY 13617
315-386-4563     315-386-4332

female pharmacist

Dr. Kristin Beverly Courtney, PHARMD, RPH


Pharmacist
111 E Main St, Canton, NY 13617
315-379-9620     866-309-3968

female pharmacist

May T Zin-lwin, RPH


Pharmacist
Miner St, Canton Plaza Rite Aid Pharmacy, Canton, NY 13617
315-386-8611    

female pharmacist

Dr. Miranda J Barksdale, PHARMD


Pharmacist
40 State Highway 310, Canton, NY 13617
315-386-4563    

male pharmacist

Mr. Peter W Macarthur


Pharmacist
40 State Highway 310, Canton, NY 13617
315-386-4563     315-386-4332

female pharmacist

Rochelle Lynn Whitton


Pharmacist
40 Ny-310, Canton, NY 13617
315-386-4563    

male pharmacist

Thomas Donahue Bobick, PHARM.D.


Pharmacist
19 Miner St, Canton, NY 13617
315-386-8611    

female pharmacist

Tiffani Lacey


Pharmacist
111 E Main St, Canton, NY 13617
315-379-9620    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.